Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.3
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jul. 31, 2019
Jul. 31, 2018
Income Statement [Abstract]    
Revenue
Expenses:    
Research and development 18,445,199 17,415,520
General and administrative 11,971,479 18,689,839
Loss from operations (30,416,678) (36,105,359)
Other income, net 440,037 374,045
Interest expense (3,805)
Loss on disposal of property and equipment (703) (875,098)
Warrant inducement expense (2,465,396)
Foreign currency exchange loss, net (281,473) (63,878)
Realized loss on sale of securities, net (12,134)
Loss before income taxes (30,274,756) (39,135,686)
Provision for income taxes 1,297 680
Net loss $ (30,276,053) $ (39,136,366)
Basic and diluted net loss per common share $ (4.29) $ (9.75)
Weighted average shares used in computing basic and diluted net loss per common share 7,053,279 4,012,337